Institution of Chemical Engineers Discusses Process Safety - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Institution of Chemical Engineers Discusses Process Safety


The Institution of Chemical Engineers (IChemE) commented on a study, which found that one in five accidents caused by equipment failures in the chemical process industries are the result of human and organizational errors, and discussed the importance of process safety in a recent press release.

“Accidents caused by equipment failures have many potential causes including contamination, corrosion, poor installation, and mechanical failures. But it is worrying to see that human and organizational failures head the list of contributing factors,” said David Brown, chief executive of IChemE, in the press release. “Competence in process safety lies at the heart of the chemical engineering skill set. Hopefully, our work over the next few years to introduce a new international qualification for process safety professionals, the development of a virtual safety center, and our ambition to promote higher standards in the corporate governance of process safety will help drive down avoidable accidents,” added Brown.

IChemE is a global professional membership organization with offices in Australia, China, Malaysia, New Zealand, Singapore and the UK. Earlier this year, IChemE published a revised technical strategy document,Chemical Engineering Matters, which outlines IChemE’s broader thinking on the areas where the profession creates, maintains, or improves quality of life. One focus of the strategy is the role of chemical engineering in process safety. 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here